Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Adoptive Cell Therapy market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Adoptive Cell Therapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category CAR-T TCR-T NK TIL Segmented by End User/Segment Lymphoma Leukemia Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Vericel Corporation SorrentoTherapeutics Regeneus Novartis NantKwest Lineage Cell Therapeutics Kite Juno Fibrocell Cellectis BioTime Bellicum Anhui Anke Biotechnology Adaptimmune

List of Figures

Figure Adoptive Cell Therapy Picture
Figure Global Adoptive Cell Therapy Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Adoptive Cell Therapy Sales Value CAGR (2020-2027) by Region
Figure Global Adoptive Cell Therapy Sales Value Market Share by Company, 2020
Figure Product Picture of CAR-T
Figure Product Picture of TCR-T
Figure Product Picture of NK
Figure Product Picture of TIL
Figure Global Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure North America Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure Europe Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure Asia Pacific Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure Central & South America Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure Middle East & Africa Adoptive Cell Therapy Sales Value Market Share by Category, 2020
Figure Adoptive Cell Therapy in Lymphoma
Figure Global Adoptive Cell Therapy Market: Lymphoma (2016-2021)
Figure Adoptive Cell Therapy in Leukemia
Figure Global Adoptive Cell Therapy Market: Leukemia (2016-2021)
Figure Global Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure North America Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Europe Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Adoptive Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Global Adoptive Cell Therapy Sales Value Market Share by Region (2016-2021)
Figure North America Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Europe Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure North America Adoptive Cell Therapy Sales Value Market Share by Country, 2020
Figure United States Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Canada Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Mexico Adoptive Cell Therapy Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Adoptive Cell Therapy Market Status and Forecast (2016-2027) 1.3.2 Global Adoptive Cell Therapy Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Adoptive Cell Therapy Supply by Company 2.1 Global Adoptive Cell Therapy Sales Value by Company 2.2 Adoptive Cell Therapy Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Adoptive Cell Therapy Market Status by Category 3.1 Adoptive Cell Therapy Category Introduction 3.1.1 CAR-T 3.1.2 TCR-T 3.1.3 NK 3.1.4 TIL 3.2 Global Adoptive Cell Therapy Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Adoptive Cell Therapy Market Status by End User/Segment 4.1 Adoptive Cell Therapy Segment by End User/Segment 4.1.1 Lymphoma 4.1.2 Leukemia 4.2 Global Adoptive Cell Therapy Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Adoptive Cell Therapy Market Status by Region 5.1 Global Adoptive Cell Therapy Market by Region 5.2 North America Adoptive Cell Therapy Market Status 5.3 Europe Adoptive Cell Therapy Market Status 5.4 Asia Pacific Adoptive Cell Therapy Market Status 5.5 Central & South America Adoptive Cell Therapy Market Status 5.6 Middle East & Africa Adoptive Cell Therapy Market Status6 North America Adoptive Cell Therapy Market Status 6.1 North America Adoptive Cell Therapy Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Adoptive Cell Therapy Market Status 7.1 Europe Adoptive Cell Therapy Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Adoptive Cell Therapy Market Status 8.1 Asia Pacific Adoptive Cell Therapy Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Adoptive Cell Therapy Market Status 9.1 Central & South America Adoptive Cell Therapy Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Adoptive Cell Therapy Market Status 10.1 Middle East & Africa Adoptive Cell Therapy Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Adoptive Cell Therapy Market Forecast by Category and by End User/Segment 12.1 Global Adoptive Cell Therapy Sales Value Forecast (2022-2027) 12.2 Global Adoptive Cell Therapy Forecast by Category 12.3 Global Adoptive Cell Therapy Forecast by End User/Segment13 Global Adoptive Cell Therapy Market Forecast by Region/Country 13.1 Global Adoptive Cell Therapy Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Vericel Corporation 14.1.1 Company Information 14.1.2 Adoptive Cell Therapy Product Introduction 14.1.3 Vericel Corporation Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 SorrentoTherapeutics 14.2.1 Company Information 14.2.2 Adoptive Cell Therapy Product Introduction 14.2.3 SorrentoTherapeutics Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Regeneus 14.3.1 Company Information 14.3.2 Adoptive Cell Therapy Product Introduction 14.3.3 Regeneus Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Novartis 14.4.1 Company Information 14.4.2 Adoptive Cell Therapy Product Introduction 14.4.3 Novartis Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 NantKwest 14.5.1 Company Information 14.5.2 Adoptive Cell Therapy Product Introduction 14.5.3 NantKwest Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Lineage Cell Therapeutics 14.6.1 Company Information 14.6.2 Adoptive Cell Therapy Product Introduction 14.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Kite 14.7.1 Company Information 14.7.2 Adoptive Cell Therapy Product Introduction 14.7.3 Kite Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Juno 14.8.1 Company Information 14.8.2 Adoptive Cell Therapy Product Introduction 14.8.3 Juno Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Fibrocell 14.9.1 Company Information 14.9.2 Adoptive Cell Therapy Product Introduction 14.9.3 Fibrocell Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Cellectis 14.10.1 Company Information 14.10.2 Adoptive Cell Therapy Product Introduction 14.10.3 Cellectis Adoptive Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 BioTime 14.12 Bellicum 14.13 Anhui Anke Biotechnology 14.14 Adaptimmune15 Conclusion16 Methodology